122 related articles for article (PubMed ID: 8697587)
1. Differential diagnosis between hepatocellular carcinoma and cirrhosis through a discriminant function based on results for serum analytes.
Castaldo G; Oriani G; Lofrano MM; Cimino L; Topa M; Budillon G; Salvatore F; Sacchetti L
Clin Chem; 1996 Aug; 42(8 Pt 1):1263-9. PubMed ID: 8697587
[TBL] [Abstract][Full Text] [Related]
2. Discriminant function based on serum analytes differentiates hepatocarcinoma from secondary liver neoplasia.
Castaldo G; Oriani G; Cimino L; Topa M; Budillon G; Salvatore F; Sacchetti L
Clin Chem; 1995 Mar; 41(3):439-43. PubMed ID: 7533673
[TBL] [Abstract][Full Text] [Related]
3. Multivariate discriminant analysis of biochemical parameters for the differentiation of clinically confounding liver diseases.
Salvatore F; Sacchetti L; Castaldo G
Clin Chim Acta; 1997 Jan; 257(1):41-58. PubMed ID: 9028625
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic efficiency in discriminating liver malignancies from cirrhosis by serum gamma-glutamyltransferase isoforms.
Sacchetti L; Castaldo G; Cimino L; Budillon G; Salvatore F
Clin Chim Acta; 1988 Oct; 177(2):167-72. PubMed ID: 2906821
[TBL] [Abstract][Full Text] [Related]
5. Serum lactate dehydrogenase isoenzyme 4/5 ratio discriminates between hepatocarcinoma and secondary liver neoplasia.
Castaldo G; Oriani G; Cimino L; Topa M; Budillon G; Salvatore F; Sacchetti L
Clin Chem; 1991 Aug; 37(8):1419-23. PubMed ID: 1651182
[TBL] [Abstract][Full Text] [Related]
6. The value of liver function tests in hepatocellular carcinoma.
Lopez JB; Balasegaram M; Thambyrajah V; Timor J
Malays J Pathol; 1996 Dec; 18(2):95-9. PubMed ID: 10879229
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the albumin-gamma-glutamyltransferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis.
Pompili M; Addolorato G; Pignataro G; Rossi C; Zuppi C; Covino M; Grieco A; Gasbarrini G; Rapaccini GL
J Gastroenterol Hepatol; 2003 Mar; 18(3):288-95. PubMed ID: 12603529
[TBL] [Abstract][Full Text] [Related]
8. Discriminant analysis in the clinical and biochemical diagnosis of primary liver cancer.
Farinati F; Varnier M; Piccoli A; Caldironi MW; Zotti S; Plebani M; Di Mario F; Naccarato R
J Med; 1986; 17(5-6):347-55. PubMed ID: 2438364
[TBL] [Abstract][Full Text] [Related]
9. Circulating gamma-glutamyltransferase fractions in cirrhosis.
Elawdi HA; Franzini M; Paolicchi A; Emdin M; Fornaciari I; Fierabracci V; De Simone P; Carrai P; Filipponi F
Liver Int; 2014 Aug; 34(7):e191-9. PubMed ID: 24387676
[TBL] [Abstract][Full Text] [Related]
10. Hepatic function testing.
Burke MD
Postgrad Med; 1978 Sep; 64(3):177-82, 185. PubMed ID: 81485
[TBL] [Abstract][Full Text] [Related]
11. Gamma-glutamyl transpeptidase in diseases of the liver and bone.
Betro MG; Oon RC; Edwards JB
Am J Clin Pathol; 1973 Nov; 60(5):672-8. PubMed ID: 4148049
[No Abstract] [Full Text] [Related]
12. A new diagnostic method for chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma based on serum metallothionein, copper, and zinc levels.
Nakayama A; Fukuda H; Ebara M; Hamasaki H; Nakajima K; Sakurai H
Biol Pharm Bull; 2002 Apr; 25(4):426-31. PubMed ID: 11995918
[TBL] [Abstract][Full Text] [Related]
13. Human alcohol dehydrogenase isoenzyme activity in the sera of non-alcoholic liver cirrhotic patients.
Chrostek L; Szmitkowski M
Eur J Clin Chem Clin Biochem; 1996 Oct; 34(10):801-4. PubMed ID: 8933102
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic effectiveness of biochemical liver-function tests, as evaluated by discriminant function analysis.
Sher PP
Clin Chem; 1977; 23(4):627-30. PubMed ID: 844156
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of liver diseases by laboratory results and discriminant analysis. Identification of best combinations of laboratory tests.
Solberg HE; Skrede S; Blomhoff JP
Scand J Clin Lab Invest; 1975 Dec; 35(8):713-21. PubMed ID: 1845
[TBL] [Abstract][Full Text] [Related]
16. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
[TBL] [Abstract][Full Text] [Related]
17. Discriminant analysis of biochemical parameters in liver disease.
Olubuyide IO; Festing MF; Chapman C; Higginson J; Whicher JT
Trop Gastroenterol; 1997; 18(1):15-9. PubMed ID: 9197166
[TBL] [Abstract][Full Text] [Related]
18. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W
Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of serum "hepatoma-specific" gamma-glutamyl transferase and alkaline phosphatase].
Xu KC
Zhonghua Zhong Liu Za Zhi; 1985 Jul; 7(4):247-9. PubMed ID: 2417791
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
